CLDX has taken a beating and then some since ASCO 2010. They have continued to deliver solid results from their pipeline and have a number of catalysts in 2011.
The stock seems to have found support at this level. Once the tax loss selling is over, I think this may have some bounce potential.
Word of caution...since PFE dumped them, there is fear of dilution to fund Phase 3 for CDX-110. On the flip side, another partner could step forward at any time.